Strategy

Market Analysis: The outlook for European pharma

Read more

New risk capital for European companies

Read more

A strategy for treating traumatic brain injury

Read more

Debate heats up over germline editing

Read more

Bioelectronics creates new horizon for medicine

Read more

Has à la carte genetic medicine arrived?

Read more

Britain looks to life outside the EU

Read more

Who is driving UK biotech investment?

Read more

Targeting diseases of ageing populations

Read more

The power of numbers in genomics research

Read more